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Introduction
The formation of synapses requires a complex interchange of 
signals between presynaptic nerve terminals and postsynaptic 
cells. This is best illustrated at the mammalian neuromuscular 
junction (NMJ), where a signaling cascade mediating post-
synaptic differentiation has been well characterized (Colledge 
and Froehner, 1998; Sanes and Lichtman, 2001; Burden, 2002; 
Bezakova and Ruegg, 2003; Song et al., 2006). At the center of 
this signaling cascade are agrin, a proteoglycan derived from 
the terminals of presynaptic motoneurons (Nitkin et al., 1987; 
Bowe and Fallon, 1995), and MuSK, a muscle-specifi  c recep-
tor tyro  sine kinase activated by agrin (Jennings et al., 1993; 
Valenzuela et al., 1995). Activation of MuSK leads to the assem-
bly of the postsynaptic complex, and genetic studies in mice 
have shown that both agrin and MuSK are required for the for-
mation of the NMJ (DeChiara et al., 1996; Gautam et al., 1996; 
Burgess et al., 1999). In particular, MuSK is required for all as-
pects of postsynaptic differentiation, including the initial agrin 
and nerve-independent clustering of nicotinic acetylcholine 
recep tors (AChRs) (Lin et al., 2001; Yang et al., 2001; Willmann 
and Fuhrer, 2002), thus functioning as the major organizer of 
synapse formation at the NMJ. It is less clear how the activity of 
MuSK is regulated to ensure proper development and homeo-
stasis of synapses.
Increasing evidence suggests that protein ubiquitination 
plays an important role in regulating synaptic development, 
maintenance, and plasticity (DiAntonio and Hicke, 2004). Pro-
tein ubiquitination is mediated by the sequential actions of three 
enzymes: an E1 ubiquitin activating enzyme, E2 ubiquitin con-
jugating enzyme, and E3 ubiquitin ligase. Of these, E3 ubiquitin 
ligases directly bind substrates and render substrate specifi  city 
to the ubiquitination reaction, thus acting as key modulators of 
the ubiquitin system. Consistent with this idea, genetic studies 
in Drosophila and Caenorhabditis elegans have demonstrated 
the importance of E3 ubiquitin ligases in synaptic development 
and function. Most notably, mutations of highwire, a putative 
E3 ubiquitin ligase in Drosophila, or its orthologue in C. elegans 
(rpm-1), lead to aberrant presynaptic development (Schaefer 
et al., 2000; Wan et al., 2000; Zhen et al., 2000; DiAntonio 
et al., 2001). Recent studies in C. elegans also suggest that E3 
ubiquitin ligases play an important role in regulating the surface 
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abundance of glutamate receptors at the postsynaptic membrane 
(Juo and Kaplan, 2004; van Roessel et al., 2004). Although am-
ple evidence supports the role of protein ubiquitination in syn-
aptic development and plasticity in vertebrates (Chapman et al., 
1992; Serdaroglu et al., 1992; Colledge et al., 2003; Patrick 
et al., 2003; Zhao et al., 2003), the specifi  c molecular mechanisms 
underlying these effects remain to be elucidated.
In the present study, we report the functional character-
ization of PDZRN3, a protein containing both RING and PDZ 
domains, as a synapse-associated E3 ubiquitin ligase at the 
mammalian NMJ. PDZRN3 (PDZ domain containing RING 
 fi nger 3) was named based on its sequence similarity to PDZRN1 
and 2 (Katoh and Katoh, 2004). It has also been named LNX3 
and SEMCAP3 based on its sequence similarity to LNX1/
LNX2 (Ligand-of-Numb protein X) and SEMCAP1/SEMCAP2 
(M-SemF cytoplasmic domain-associated protein), respectively. 
A very recent study showed that PDZRN3 is expressed in muscle 
(Ko et al., 2006). In culture, the expression of PDZRN3 is in-
creased during differentiation of myoblasts to myotubes and may 
play a role in myoblast fusion (Ko et al., 2006). We fi  nd that 
PDZRN3 mRNA is enriched in the synaptic region of the mus-
cle and that PDZRN3 protein is concentrated at the NMJ. Co-
immunoprecipitation shows that PDZRN3 interacts with MuSK 
in heterologous cells and in myotubes, and that this interaction is 
enhanced by agrin stimulation. Functionally, PDZRN3 promotes 
ubiquitination of MuSK and down-regulates cell surface levels 
of MuSK through its E3 ubiquitin ligase domain. Both gain- 
and loss-of-function studies in cultured myotubes reveal an 
im  portant role for PDZRN3 in regulating agrin-induced AChR 
clustering. Furthermore, transgenic overexpression of PDZRN3 
in vivo perturbs the growth and maturation of the NMJ. Our 
fi  ndings demonstrate an important role for PDZRN3 in regulat-
ing the growth and maturation of the NMJ.
Results
PDZRN3 interacts with MuSK
PDZ domain–mediated protein–protein interactions play im-
portant roles at synapses (Kim and Sheng, 2004). Many synap-
tic proteins at the mammalian NMJ, including MuSK, ErbB2, 
neuregulin-1, and Eph receptors, contain conserved PDZ bind-
ing motifs at the C termini (Torres et al., 1998), suggesting that 
PDZ domain proteins may also play a role at the NMJ. Our pre-
vious yeast two-hybrid screen using the last 25 amino acids of 
erbB2 and neuregulin-1 as baits identifi  ed Lnx1 as an ErbB2-
interacting, PDZ domain–containing E3 ubiquitin ligase that is 
exclusively expressed in perisynaptic Schwann cells at the NMJ 
(Young et al., 2005). We then searched databases for additional 
RING and PDZ domain–containing proteins that may play a 
role at the NMJ and identifi  ed PDZRN3 as a potential candi-
date. Structurally, PDZRN3 (also called SEMCAP3 and LNX3; 
Katoh and Katoh, 2004; Ko et al., 2006) contains a RING do-
main, a zinc fi  nger domain, one (PDZRN3A) or two (PDZRN3B) 
PDZ domains depending on alternative splicing, and a PDZ do-
main binding motif (TTV) at the C terminus (Fig. 1 A). Northern 
blot analysis indicates that there are two species of PDZRN3 
mRNA with molecular sizes of 5.5 and 4.6 kb. Both splicing 
variants are highly expressed in skeletal and cardiac muscle of 
adult mice. Lower levels of expression are also seen in the brain, 
spinal cord, kidney, and lung (Fig. 1 B). Examination of mRNA 
expression by in situ hybridization of the diaphragm shows that 
PDZRN3 mRNA is expressed throughout muscle fi  bers with a 
distinct enrichment at the central region of the diaphragm mus-
cle where synapses and synaptic nuclei are localized (Fig. 1 C), 
suggesting that PDZRN3 mRNA is preferentially transcribed 
by synaptic nuclei and thus may play a role at the NMJ.
Because MuSK contains a conserved PDZ binding motif 
at its C terminus (Torres et al., 1998) we tested whether PDZRN3 
interacts with MuSK by coexpressing MuSK and PDZRN3A in 
COS-7 cells. As shown in Fig. 1 D, MuSK can be specifi  cally 
coimmunoprecipitated with PDZRN3A, suggesting a direct 
interaction between MuSK and PDZRN3A. As a control, we 
found that Cbl, a well-characterized RING-type E3 ubiquitin 
ligase (Levkowitz et al., 1999), does not interact with MuSK 
under the same conditions (Fig. 1 E). To test whether PDZRN3 
interacts with MuSK under physiological conditions, we immuno-
precipitated MuSK from cultured myotubes and found that 
PDZRN3 was coimmunoprecipitated with MuSK, indicating 
that they form a complex in myotubes (Fig. 1 F). Moreover, 
agrin stimulation signifi  cantly increased the association of MuSK 
and PDZRN3 in cultured myotubes (Fig. 1 G), suggesting a 
dynamic regulation of PDZRN3 and MuSK interaction.
To determine which domain(s) in the PDZRN3 protein 
mediates the interaction with MuSK, we made deletion con-
structs of PDZRN3A that lacked either the RING and zinc fi  n-
ger domains or the PDZ domain. When coexpressed with MuSK 
in COS-7 cells, PDZRN3A lacking the RING and zinc fi  nger 
domains retained the ability to interact with MuSK, whereas 
PDZRN3A lacking the PDZ domains failed to interact with 
MuSK (Fig. 1 H). This suggests that the PDZ domain in 
PDZRN3A is required for its interaction with MuSK. However, 
deletion of the PDZ binding motif of MuSK only partially de-
creased its interaction with PDZRN3A (Fig. 1 I), suggesting 
that the PDZ domains of PDZRN3A may interact with internal 
sequences as well as the C-terminal motif on the cytoplasmic 
domain of MuSK. To further dissect the interaction of MuSK 
with PDZRN3A, we coexpressed full-length PDZRN3A with a 
series of deletion constructs of MuSK lacking the PDZ binding 
motif (last 3 amino acids). Coimmunoprecipitation data showed 
that, in the absence of the PDZ binding motif, a large portion of the 
kinase domain of MuSK is required for binding to PDZRN3A 
(Fig. 1 J). However, inclusion of the terminal PDZ binding 
motif (TTV) in deletion constructs of MuSK is suffi  cient to restore 
the binding with PDZRN3A (Fig. 1, J and K), indicating that 
the PDZ binding motif of MuSK is suffi  cient but not necessary 
for its binding to PDZRN3A in a heterologous system.
PDZRN3 proteins are concentrated 
postsynaptically at the NMJ
To examine the localization of PDZRN3 proteins, we generated 
a rabbit polyclonal antibody against the N-terminal RING do-
main (PDZRN3-10B) and a guinea pig polyclonal antibody 
against an internal unique sequence (PDZRN3-3B). Both affi  nity-
purifi  ed antibodies specifi  cally recognized a single band from E3 UBIQUITIN LIGASE AT THE NMJ • LU ET AL. 1079
C2C12 myotube lysates which corresponded to the size of the 
shorter PDZRN3 isoform (PDZRN3A in Fig. 1 A) from trans-
fected COS-7 cells (Fig. 2, A and B), suggesting that PDZRN3A is 
the predominant form in myotubes. Consistent with the Northern 
blot result, PDZRN3 proteins are detectable in skeletal muscle, 
heart, spinal cord, and brain (Fig. 2 C).
To determine the localization of PDZRN3 proteins in the 
neuromuscular system, we performed coimmunostaining of adult 
mouse muscle with anti-PDZRN3 antibodies and α-bungarotoxin 
(α-BTX), which specifi  cally binds nicotinic acetylcholine recep-
tors (AChRs). Both anti-PDZRN3 antibodies stain the NMJ 
brightly with a pattern that precisely matches the staining of 
AChRs with α-BTX (Fig. 2; D–D′′, E–E′′). The staining is spe-
cifi  c as it can be blocked by preincubation of the antibodies with 
cognate antigens (Fig. 2, F–F′′). To determine whether PDZRN3 
is localized postsynaptically, we denervated hindlimb muscles in 
adult mice by transection of the sciatic nerve on one side of the 
body, and compared the expression of PDZRN3 in denervated 
and non-denervated muscles using triple labeling of α-BTX, anti-
synaptophysin, and anti-PDZRN3. 5 d after nerve resection, pre-
synaptic nerve terminals had degenerated as revealed by the lack of 
staining for the presynaptic vesicle protein synaptophysin, whereas 
staining for AChRs (Fig. 2, H–H′) and MuSK (Fig. S1 [avail-
able at http://www.jcb.org/cgi/content/full/jcb.200610060/DC1]; 
Figure 1.  Interaction of MuSK with PDZRN3. 
(A) Protein domain structure of PDZRN3. Two splic-
ing variants were identiﬁ   ed. The major form of 
PDZRN3 (PDZRN3A) contains a RING ﬁ  nger 
  domain (RF), a zinc ﬁ   nger domain (ZF), a PDZ 
  domain (PDZ-1), and a PDZ binding motif (TTV). 
The longer form (PDZRN3B) contains an additional 
PDZ domain (PDZ-2). (B) Northern blot shows two 
species of PDZRN3 mRNA with molecular sizes of 
5.5 and 4.6 kb. PDZRN3 is highly expressed in 
skeletal and cardiac muscle. Lower expression is 
also seen in the spinal cord, brain, kidney, and lung. 
The blot was re-probed with elongation factor-1α 
(EF-1α) as a loading control. (C) Wholemount in 
situ hybridization of diaphragm from P7 mice re-
veals that PDZRN3 mRNA is concentrated at the 
central region of the muscle, suggesting that 
PDZRN3 mRNA is preferentially transcribed by 
synaptic nuclei. Lower level of PDZRN3 mRNA 
is also expressed throughout the muscle ﬁ  bers. 
(D) PDZRN3 interacts with MuSK in transfected 
COS-7 cells. PDZRN3A and MuSK were cotrans-
fected into COS-7 cells. Immunoprecipitations (IP) 
were performed using an anti-PDZRN3 antibody and 
immunoblotted (IB) with an anti-MuSK antibody. 
MuSK and PDZRN3A were coimmunoprecipi-
tated. Lysate lanes represent 10% of the input for 
coimmunoprecipitation. (E) A control experiment 
shows that Cbl, a RING-type E3 ubiquitin ligase, 
does not coimmuniprecipitate with MuSK when 
coexpressed in COS-7 cells. (F) PDZRN3 and 
MuSK form a complex in myotubes. Lysates from 
cultured C2C12 myotubes were immunoprecipi-
tated with an anti-MuSK antibody and blotted 
with an anti-PDZRN3 antibody. Lysate lanes repre-
sent 5% of the input for coimmunoprecipitation. 
(G) Agrin stimulation enhances the interaction of 
PDZRN3 and MuSK. Lysates of cultured C2C12 
myotubes with or without agrin stimulation were 
immunoprecipitated with an anti-MuSK antibody 
and blotted with an anti-PDZRN3 antibody. An 
increased amount of PDZRN3 was coimmuno-
precipitated with MuSK from agrin-stimulated myo-
tubes. Lysate lanes represent 5% of the input for 
coimmuno  precipitation. (H) The PDZ domain of 
PDZRN3 is required for its interaction with MuSK. 
Lysates from COS-7 cells expressing MuSK and ei-
ther PDZRN3A, PDZRN3A lacking the RING and 
zinc ﬁ  nger domains (PDZRN3A∆RZ), or PDZRN3A 
lacking the PDZ domain (PDZRN3A∆PDZ) were 
immunoprecipitated with an anti-PDZRN3 antibody and blotted with an anti-MuSK antibody. Deletion of the PDZ domain from PDZRN3A completely abol-
ished its interaction with MuSK. (I) The PDZ domain binding motif of MuSK is not necessary for its binding to PDZRN3. MuSK lacking the PDZ domain bind-
ing motif (deletion of the last three amino acids; MuSK∆3) was coexpressed with PDZRN3A in COS-7 cells and coimmunoprecipitation was performed with 
an anti-PDZRN3 antibody. (J and K) Deletion mapping suggests that in the absence of the PDZ binding motif a large portion of the kinase domain of MuSK 
mediates the interaction with PDZRN3 (J). Only the transmembrane domain and the cytoplasmic domain are shown in the diagram. JXT = juxtamembrane 
domain. However, the presence of the PDZ binding motif (TTV) in the deletion construct of MuSK (∆C2+TTV) restores its ability to interact with PDZRN3 (K), 
indicating that the PDZ binding motif of MuSK is sufﬁ  cient but not necessary for its interaction with PDZRN3.JCB • VOLUME 177 • NUMBER 6 • 2007  1080
Bowen et al., 1998) remained. PDZRN3 staining persis  ted at the 
denervated NMJ and colocalized with AChR staining (Fig. 2, 
H–H′′), indicating that PDZRN3 is localized at the postsynaptic 
site of the NMJ, consistent with a potential role in regulating 
MuSK signaling.
The developmental profi  le of PDZRN3 expression at the 
NMJ was examined by immunostaining of muscle sections 
from various developmental stages. PDZRN3 staining at the 
NMJ fi  rst appears at approximately embryonic day (E) 16.5 
(Fig. 2 I), a time point when NMJs have just formed. As the 
NMJ grows and matures, the staining intensity and complexity 
of PDZRN3 increases in concert with that of AChRs (Fig. 2 I), 
a developmental profi  le common to known postsynaptic regula-
tors at the NMJ, such as MuSK and rapsyn (Noakes et al., 1993; 
Bowen et al., 1998).
PDZRN3 promotes MuSK ubiquitination
The presence of a classic RING domain with conserved key 
cysteine and histidine residues in the PDZRN3 protein suggests 
that PDZRN3 likely functions as a RING-type E3 ubiquitin ligase. 
To test this, we used an in vitro ubiquitination assay to examine 
whether the RING domain of PDZRN3 contains E3 ubiquitin 
ligase activity. The RING domain of PDZRN3 was fused to GST 
and expressed in Escherichia coli. Glutathione bead-purifi  ed 
GST fusion proteins were tested for self-ubiquitination in the 
presence of added E1 and E2 enzymes. Currently, more than two 
dozen E2 enzymes have been identifi  ed, and they show varying 
degrees of specifi  city when interacting with E3s (Kumar et al., 
1997). Our initial tests of various E2s showed that the RING 
domain of PDZRN3 exhibits ubiquitin ligase activity in the 
presence of E1 and the UbcH5 family of E2 enzymes (Fig. 3 A). 
Consistent with this fi  nding, GST pull-down assays showed that 
PDZRN3 directly interacts with the UbcH5B ubiquitin conju-
gating enzyme (Fig. 3 B). Furthermore, mutation of either one of 
the two key cysteines in the RING structure completely abolished 
the ubiquitin ligase activity of PDZRN3 (Fig. 3 C). Together, 
these data demonstrate that PDZRN3 is a catalytically active 
RING-type E3 ubiquitin ligase.
We next tested whether PDZRN3 promotes the ubiqui-
tination of MuSK. MuSK was cotransfected with PDZRN3A, 
Figure 2.  PDZRN3 is localized postsynaptically at the NMJ. (A and B) Characterization of a rabbit (PDZRN3-10B) and a guinea pig (PDZRN3-3B) anti-
body against PDZRN3. Both afﬁ  nity-puriﬁ  ed antibodies recognize a single band in myotube lysate corresponding to the size of PDZRN3A transiently 
expressed in COS-7 cells. (C) A Western blot shows that PDZRN3 protein is expressed in the skeletal muscle, heart, brain, and spinal cord. (D and E) Cross 
sections of adult mouse muscle were co-stained with α-bungarotoxin (BTX; D and E), which binds to AChRs, and either PDZRN3-10B antibody (D′) or 
PDZRN3-3B antibody (E′). PDZRN3 precisely colocalizes with AChRs at the NMJ (D′′ and E′′). (F) The synaptic staining of PDZRN3 is blocked by incubat-
ing the antibody with the immunizing antigen. (G and H) PDZRN3 localizes postsynaptically. Cross sections from innervated (G) or denervated (H) muscles 
were triple stained with α-BTX for postsynaptic AChRs (blue; G and H), anti-synaptophysin for presynaptic nerve terminals (green; G′and H′) and PDZRN3 
(red; G′′ and H′′). 5 d after denervation, presynaptic terminals had degenerated (H′), but PDZRN3 staining persisted (H′′). (I) Developmental proﬁ  le of 
PDZRN3 expression at the NMJ. Cross sections of muscles were prepared from mice at embryonic day (E) 14.5, 16.5, 18.5, postnatal day (P) 3, 7, and 21, 
and co-stained with α-BTX and PDZRN3. PDZRN3 staining ﬁ  rst appears at E16.5. Bars, 10 μm.E3 UBIQUITIN LIGASE AT THE NMJ • LU ET AL. 1081
PDZRN3A∆RING (PDZRN3A lacking the RING domain), or 
PDZRN3A∆PDZ (lacking the PDZ domains) into cultured 
COS-7 cells. Transfected cells were harvested in the presence of 
2% SDS and incubated at 4°C for 1 h to minimize nonspecifi  c 
association of proteins with MuSK. MuSK was immunoprecipi-
tated with anti-MuSK antibodies and analyzed by Western blot 
for ubiquitination using an anti-ubiquitin antibody. In the ab-
sence of PDZRN3A, MuSK from transfected COS-7 cells 
showed low levels of ubiquitination (Fig. 3 D). When MuSK 
was coexpressed with PDZRN3A, the levels of MuSK ubiqui-
tination were signifi  cantly increased (Fig. 3 D). Deletion of the 
RING domain, which contains the E3 ubiquitin ligase activity, 
or the PDZ domain, which is required for the interaction with 
MuSK, completely abolished the effects of PDZRN3A on 
the ubiquitination of MuSK (Fig. 3 D). On the other hand, co-
expression of PDZRN3A and TrkB, a functionally unrelated 
receptor tyrosine kinase, did not lead to increased ubiquitina-
tion of TrkB (Fig. 3 E). These data strongly suggest that MuSK 
is a specifi  c substrate of PDZRN3 ubiquitin ligase activity.
To determine whether endogenous MuSK in myotubes 
is ubiquitinated, we immunoprecipitated MuSK from agrin-
treated and nontreated myotubes and probed for MuSK ubiqui-
tination using an anti-ubiquitin antibody. In the absence of agrin 
stimulation, a low level of MuSK ubiquitination was observed. 
However, the level of ubiquitination of MuSK was signifi  cantly 
increased upon agrin stimulation (Fig. 3 F). Together with the 
results showing the enhancement of MuSK and PDZRN3 inter-
action upon agrin stimulation, these data suggest that the ubiq-
uitnation of MuSK is dynamically regulated and PDZRN3 may 
play an important role in this regulation.
Regulation of cell surface levels of MuSK 
by PDZRN3
To determine the functional consequences of MuSK-PDZRN3 
interaction, we tested whether PDZRN3 directly regulates the 
level of MuSK on the cell surface. We coexpressed PDZRN3A 
and MuSK in COS-7 cells and measured cell surface levels of 
MuSK by membrane nonpermeable biotinylation of surface 
Figure 3.  PDZRN3 is an E3 ubiquitin ligase and 
promotes MuSK ubiquitination. (A) The RING do-
main of PDZRN3 was fused to GST and puriﬁ  ed 
from E. coli. In vitro self-ubiquitination assays were 
performed in the presence of ubiquitin, E1, and 
various E2s. Self-ubiquitination of RING-GST (arrow) 
was only seen in the presence of the UbcH5 
family of E2s. The arrowhead indicates the non-
ubiquitinated RING-GST fusion protein. (B) GST 
pull-down experiment shows a direct interaction 
between UbcH5B and PDZRN3. GST or GST-
UbcH5B proteins were immobilized on glutathione-
sepharose beads. Whole cell lysates from PDZRN3 
transfected COS-7 cells were incubated with GST 
or GST-UbcH5B beads and proteins were eluted. 
Western blot analysis shows that PDZRN3 was 
pulled down by GST-UbcH5B beads. (C) In vitro 
self-ubiquitination assay shows that mutation of 
the key cysteine residues in the RING domain of 
PDZRN3 (C18A and C38A) completely abolishes 
its ubiquitin ligase activity. The blot was ﬁ   rst 
probed with an anti-FLAG antibody for the FLAG-
tagged GST-RING proteins (top panel), then blot-
ted with an anti-ubiquitin antibody to conﬁ  rm the 
ubiquitination (bottom panel). (D) PDZRN3 pro-
motes MuSK ubiquitination. MuSK was coex-
pressed with PDZRN3A, PDZRN3A lacking the 
RING domain (PDZRN3A∆RING) or PDZRN3A 
lacking the PDZ domains (PDZRN3A∆PDZ) in 
COS-7 cells. MuSK was immunoprecipitated with 
an anti-MuSK antibody and analyzed by Western 
blot with an anti-ubiquitin antibody to detect 
ubiquitination of MuSK. Only wild-type PDZRN3A 
promotes MuSK ubiquitination. (E) Coexpression 
of PDZRN3 and TrkB does not lead to increased 
ubiquitination of TrkB. TrkB was coexpressed with 
PDZRN3A in COS-7 cells. Coimmuno precipitation 
was performed with an anti-TrkB anti  body and 
blotted with an anti-ubiquitin antibody. (F) MuSK 
ubiquitination is increased upon agrin stimulation. 
Lysates from agrin-treated (1 nM for 2 h) and 
nontreated cultured myotubes were immuno-
precipitated with an anti-MuSK antibody and blot-
ted with an anti-ubiquitin antibody (top panel). 
The blot was reprobed with an anti-MuSK anti-
body to show the immunoprecipitated MuSK 
(bottom panel).JCB • VOLUME 177 • NUMBER 6 • 2007  1082
proteins and subsequent quantifi  cation of biotinylated MuSK 
by Western blot. Coexpression of PDZRN3A with MuSK signi-
fi  cantly reduced the surface level of MuSK (Fig. 4, A and B). This 
effect was seen with both wild-type and constitutively kinase-
active MuSK. Interestingly, PDZRN3A did not down-regulate 
the surface level of kinase-dead MuSK, which retains partial 
ability to interact with PDZRN3A (Fig. 4 C), suggesting that the 
effect of PDZRN3A on surface MuSK levels depends on the 
kinase activity of MuSK. This is consistent with our observation 
that agrin stimulation, which activates MuSK kinase activity, en-
hances the MuSK-PDZRN3 interaction and MuSK ubiquitina-
tion. This is also consistent with other studies showing that E3 
ubiquitin ligases are often activated by the kinase activity of the 
receptor tyrosine kinases they regulate (Levkowitz et al., 1999; 
Miyake et al., 1999; Marmor and Yarden, 2004).
Because the RING domain contains the ubiquitin ligase 
activity, we examined whether the RING domain of PDZRN3 
is required for the down-regulation of the surface level of 
MuSK using a PDZRN3A construct lacking the RING domain. 
As shown in Fig. 4 D, deletion of the RING domain abolishes 
the effect of PDZRN3 on the surface level of MuSK, suggesting 
that the E3 ubiquitin ligase activity of PDZRN3 plays a criti-
cal role in this regulation. To test the specifi  city of the effect 
of PDZRN3 on MuSK surface expression, we coexpressed 
PDZRN3A with erbB2, another receptor tyrosine kinase present 
at the NMJ. We found that PDZRN3A did not affect the surface 
level of erbB2 (Fig. S2 A, available at http://www.jcb.org/
cgi/content/full/jcb.200610060/DC1). Moreover, the surface 
level of MuSK is not down-regulated by Cbl (Fig. S2 B), a 
RING-type E3 ubiquitin ligase that has been shown to down-
regulate the signaling of several receptor tyrosine kinases such 
as PDGF and EGF receptors (Levkowitz et al., 1999; Miyake 
et al., 1999). These data strongly suggest that PDZRN3 specif-
ically regulates the surface levels of MuSK through the com-
bination of its specifi  c binding to MuSK and its E3 ubiquitin 
ligase activity.
The ubiquitin system is best known for its function of 
adding polyubiquitin chains to target proteins, leading to the 
degradation of polyubiquitinated proteins through the 26S 
proteasome. However, a more recently discovered function of 
the ubiquitin system is to regulate membrane protein endo-
cytosis through mono- or poly-ubiquitination (Hicke, 2001; 
Barriere et al., 2006; Hawryluk et al., 2006). To test whether 
PDZRN3 regulates MuSK activity through endocytosis, we 
compared the relative endocytosis of MuSK in the absence or 
presence of PDZRN3. To measure the endocytosis of MuSK, 
surface proteins from two identical sets of cells were biotinyl-
ated at 4°C. One set of biotinylated cells was kept on ice and 
used to measure initial surface levels of MuSK. The other set 
of biotinylated cells was moved to 37°C for 10 min to allow 
endocytosis to occur, and the remaining biotinylated surface 
proteins were then cleaved. Surface and endocytosed MuSK 
were detected by Western blot. The relative endocytosis was 
calculated as the ratio of endocytosed versus initial surface 
MuSK. As expected, expression of PDZRN3A reduced the 
surface level of MuSK (Fig. 4 E). This reduction of surface 
Figure 4.  PDZRN3 regulates the surface levels of 
MuSK. (A and B) PDZRN3 down-regulates surface 
levels of MuSK in COS-7 cells. PDZRN3A was co-
expressed with wild-type (WT), kinase-active (KA), 
or kinase-dead (KD) MuSK in COS-7 cells and the 
surface levels of MuSK were determined by bioti-
nylation assays followed by Western blot of MuSK. 
Coexpression of PDZRN3A leads to reduced sur-
face levels of wild-type and kinase-active MuSK, 
but not kinase-dead MuSK. Transferrin receptors 
(TfR) were used as a control for surface biotiny-
lation and GAPDH was used as a control of cell 
number. Bar graphs in B show the quantiﬁ  cation 
data (mean ± SEM, n = 6). *, P < 0.05; **, P < 
0.01. (C) Kinase-dead MuSK retains its ability to 
interact with PDZRN3. PDZRN3A and MuSK were 
cotransfected into COS-7 cells and immunoprecip-
itations were performed using an anti-PDZRN3 
antibody. Both kinase-active (KA) and kinase-
dead (KD) MuSK were coimmunoprecipitated with 
PDZRN3A. (D) PDZRN3A construct lacking the RING 
domain (PDZRN3A∆RING) was coexpressed with 
MuSK and the surface level of MuSK was deter-
mined as described above. Deletion of the RING 
domain abolishes the effect of PDZRN3A on the 
down-regulation of MuSK surface levels. (E and F) 
Relative endocytosis of MuSK in the presence and 
absence of PDZRN3A. The initial surface (E, left 
panel) and subsequent endocytosed MuSK (E, right 
panel) were determined by biotinylation assays, 
and relative endocytosis was calculated as the 
ratio of endocytosed/initial surface MuSK (F; 
mean ± SEM, n = 6). Coexpression of PDZRN3A 
with MuSK signiﬁ  cantly increased the endocytosis 
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expression of MuSK was accompanied by increased endo-
cytosis of MuSK (Fig. 4 E). In the presence of PDZRN3A, the 
ratio of endocytosed MuSK to initial surface MuSK is twice 
that of MuSK alone (Fig. 4, E and F).
Ubiquitination of membrane proteins generally leads to 
  endocytosis and subsequent degradation through the lysosome 
(Hicke, 2001; Marmor and Yarden, 2004). Consistent with our 
observation that PDZRN3 down-regulates the surface level of 
MuSK by increasing its endocytosis, we found that the addition 
of chloroquine (CLQ), a lysosome inhibitor that blocks lyso-
somal degradation and membrane recycling (Tietze et al., 1980; 
Levkowitz et al., 1999; Rocca et al., 2001; Vecchione et al., 
2003), largely abolished the effect of PDZRN3 on MuSK surface 
expression. In contrast, blocking 26S proteasome function with 
MG-132 did not affect the PDZRN3-mediated down-regulation 
of MuSK surface expression (Fig. S3, available at http://www
.jcb.org/cgi/content/full/jcb.200610060/DC1).
PDZRN3 regulates agrin-induced AChR 
clustering in myotubes
To investigate the functional significance of PDZRN3 in 
  regulating MuSK signaling, we examined MuSK-dependent 
AChR clustering in cultured myotubes. We used cultured 
C2C12 myoblasts, which differentiate into myotubes upon 
serum deprivation. The clustering of AChRs on these myotubes 
can be effi  ciently induced by the addition of exogenous agrin 
(Pun et al., 1997), thus providing a system to dissect agrin–
MuSK signaling without the interference of other factors from 
nerve terminals. Agrin stimulation of wild-type myotubes 
leads to the formation of numerous large clusters of AChRs 
(Fig. 5, A and G). However, agrin-induced AChR clustering 
is signifi  cantly attenuated in myotubes overexpressing either 
form of PDZRN3 (Fig. 5; A–A′′, B–B′′, G). Importantly, the 
deletion of the RING domain largely abolishes this effect 
(Fig. 5; C–C′′, D–D′′, G). Furthermore, coexpression of MuSK 
with PDZRN3 in myotubes blocks the effect of PDZRN3 on 
agrin-induced AChR clustering (Fig. 5; E–E′′, F–F′′, G), suggest-
ing that overexpression of MuSK can antagonize PDZRN3. 
These data are consistent with our observation that PDZRN3 
down- regulates the surface levels of MuSK when coexpressed 
in COS-7 cells and point to a potential role for PDZRN3 as an 
E3 ubiquitin ligase regulating postsynaptic development at 
the NMJ.
Knockdown of PDZRN3 in myotubes leads 
to increased surface levels of MuSK
To further understand the role of PDZRN3 in regulating MuSK 
signaling, we performed a loss-of-function study using small 
Figure 5.  Overexpression of PDZRN3 in myotubes dis-
rupts agrin-induced clustering of AChRs. (A and B) Trans-
fected myotubes were stimulated with agrin and stained 
with α-BTX (green) and PDZRN3 (red). Overexpression of 
PDZRN3A (A) or PDZRN3B (B) attenuates agrin-induced 
clustering of AChRs in cultured myotubes. Arrows indicate 
transfected myotubes and arrowheads indicate untrans-
fected myotubes. (C and D) Myotubes were transfected 
with PDZRN3 constructs lacking the RING domain 
(∆RING). After agrin stimulation, myotubes were stained 
with  α-BTX (green) and PDZRN3 (red). Deletion of the 
RING domain abolishes the effect of PDZRN3 on agrin-
  induced AChR clustering. (E and F) Myotubes were trans-
fected with MuSK and PDZRN3 constructs. After agrin 
stimulation, myotubes were stained with α-BTX (green) 
and PDZRN3 (red). Coexpression of MuSK with PDZRN3 
blocks the effect of PDZRN3 on agrin-induced AChR clus-
tering. Bar, 50 μm. (G) Quantiﬁ  cation of the number of 
AChR clusters in cultured myotubes. N (the number of 
myotubes) is shown inside bars (from three separate 
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interfering RNA (siRNA)–mediated knockdown of endogenous 
PDZRN3 in cultured myotubes. We designed four siRNAs tar-
geting different regions of the PDZRN3 sequence, tested their 
ability to knockdown PDZRN3 expression in cotransfected 
COS-7 cells (unpublished data), and selected an effective one 
for use in myotubes.
Myotubes are multinucleated cells fused from individ-
ual myoblasts. To maximize the number of myoblasts ex-
pressing the siRNA constructs, we transfected myoblasts with 
siRNA constructs containing a Neo cassette in the vector. 
We then pooled all stably transfected myoblasts using G418 
selection. These stably transfected myoblasts were cultured 
to fuse into myotubes, and they were found to fuse in a fash-
ion indistinguishable from that of wild-type C2C12 cells 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200610060/DC1). Western blot analysis of endogenous 
PDZRN3 showed that myotubes expressing siRNA constructs 
have signifi  cantly reduced levels of endogenous PDZRN3 
compared with myotubes expressing scrambled siRNA con-
structs (Fig. 6, A and B).
To determine the effect of knockdown of PDZRN3 on 
MuSK signaling, we fi  rst measured the surface level of MuSK 
using biotinylation assays. As shown in Fig. 6 (C and D), the 
surface level of MuSK in myotubes expressing the siRNA con-
struct is signifi   cantly increased, indicating that endogenous 
PDZRN3 plays an important role in regulating the surface level 
of MuSK on myotubes. We next tested whether the increased 
surface level of MuSK in PDZRN3 knockdown myotubes also 
leads to an enhanced response to agrin stimulation. When stim-
ulated with a saturating concentration of agrin (1 nM), myotubes 
expressing the PDZRN3 siRNA construct and the scrambled 
siRNA construct showed a similar response as measured by the 
number of AChR clusters (last data point in Fig. 6 E), suggesting 
that myotubes stably transfected with siRNA constructs are 
capable of forming AChR clusters when stimulated with agrin. 
We then determined the dose–response curve of agrin stimulation. 
We found that at low concentrations of agrin, myotubes ex-
pressing the siRNA construct showed an enhanced response as 
indicated by the increased number of AChR clusters (Fig. 6, 
E and F). Furthermore, increased MuSK ubiquitination induced 
by agrin stimulation was not detected in myotubes expressing 
the PDZRN3 siRNA construct (Fig. 6 G). Together with the re-
sults from the gain-of-function studies, these data suggest a 
mechanism by which the activity of MuSK is regulated by the 
synapse-associated E3 ubiquitin ligase PDZRN3 to regulate 
postsynaptic development.
Figure 6.  Knockdown of PDZRN3 by siRNA increases the 
surface expression of MuSK and enhances the sensitivity of 
myotubes to agrin stimulation. (A and B) pSuper vector 
based siRNA constructs for PDZRN3 or scrambled se-
quence (SCR) were stably transfected in C2C12 myoblasts. 
PDZRN3 proteins in myotubes fused from these cells are 
  reduced to  25% of the controls (mean ± SEM, n = 6). 
**, P < 0.01. (C and D) Surface levels of MuSK in these 
stably siRNA transfected C2C12 myotubes were deter-
mined by biotinylation assays. Knockdown of PDZRN3 in 
myotubes signiﬁ  cantly increased the surface levels of MuSK 
(mean ± SEM, n = 6). **, P < 0.01. (E and F) Myotubes 
were treated with various concentrations of agrin and 
stained with α-BTX for AChR clusters. The number of agrin-
induced AChR clusters at the lowest concentration of agrin 
(0.01 nM) is signiﬁ   cantly increased in myotubes fused 
from C2C12 cells stably transfected with the PDZRN3 
RNAi construct. In E, triangles (∆) represent siRNA-PDZRN3 
and squares (□) represent siRNA-scrambled (SCR). Data 
are shown as mean ± SEM, n = 20 from three separate 
experiments. *, P = 0.01. Images in F show representative 
views of the myotubes stimulated with 0.01 nM agrin. Bar 
(F), 50 μm. (G) Knockdown of PDZRN3 in cultured myo-
tubes diminishes agrin-induced ubiquitination of MuSK. 
Lysates were prepared from agrin-treated (1 nM for 2 h) 
and nontreated C2C12 myotubes expressing siRNA for 
PDZRN3 (siRNA) or a scrambled sequence (SCR). MuSK 
was immunoprecipitated with an anti-MuSK antibody and 
ubiquitination of MuSK was detected with an anti-ubiquitin 
antibody. As in the wild-type myotubes, ubiquitination of 
MuSK is increased upon agrin stimulation in myotubes 
  expressing a scrambled sequence. This agrin-induced in-
crease of MuSK ubiquitination is diminished in myotubes 
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Overexpression of PDZRN3 in skeletal 
muscle perturbs the growth and 
maturation of the NMJ in transgenic mice
To test whether modulation of PDZRN3 levels affect the devel-
opment of the NMJ in vivo, we generated transgenic mice which 
overexpress PDZRN3 in skeletal muscle. We used the well-
characterized promoter/enhancer elements from the myosin light 
chain (MLC) 1f/3f gene to drive HA-tagged PDZRN3A ex-
pression (Fig. 7 A). MLC 1f/3f promoter/enhancer elements 
have been shown to drive high levels of transgene expression in 
skeletal muscle but not in nonmuscle cells (Rosenthal et al., 
1989; Feng et al., 2000).
Four transgenic founder lines were established and the 
line with the highest HA-PDZRN3A expression (named MLC-
PDZRN3A) was selected for further study. MLC-PDZRN3A 
transgenic mice were born at an expected rate and have normal 
body size up to 1 wk after birth. However, by the age of 3 wk, 
the transgenic mice were signifi  cantly smaller than wild-type 
littermates, with their bodyweight at 50–75% of the wild-type 
littermates. No other phenotypical abnormalities were observed 
and most of the transgenic mice survive to adulthood. Histological 
examination of muscles showed no sign of muscle degeneration/
regeneration (unpublished data).
RT-PCR showed that HA-PDZRN3A transcripts are specif-
ically expressed in the skeletal muscle (Fig. 7 B). The expression 
of mRNA and protein of HA-PDZRN3A could be detected as 
early as E15.5 (Fig. 7, C and D). Quantifi  cation of proteins from 
muscles of P21 mice indicates that there is a 1.8-fold increase of 
PDZRN3 proteins in transgenic mice compared with wild-type 
littermates (182 ± 6.9% of wildtype controls, n = 3; Fig. 7 E). 
Immunostaining showed that, like endogenous PDZRN3, HA-
PDZRN3A is concentrated at the NMJ as revealed by co-staining 
with anti-HA antibodies and α-BTX (Fig. 7 F).
To determine the effects of overexpression of PDZRN3A 
on the development of the NMJ, we fi  rst examined MuSK ex-
pression at the NMJ in MLC-PDZRN3A transgenic mice by 
immunostaining with a polyclonal anti-MuSK antibody (Herbst 
et al., 2002). In muscles of wild-type mice, MuSK is highly 
concentrated at the NMJ and precisely colocalized with AChRs 
(Fig. 7 G). In the MLC-PDZRN3A transgenic mice, a similar 
pattern of MuSK staining was observed. However, the intensity of 
the immunostaining of MuSK in the MLC-PDZRN3A transgenic 
Figure 7.  Overexpression of PDZRN3 in skeletal   muscle 
of transgenic mice perturbs the development of the NMJ. 
(A) A diagram of the transgene, in which HA-tagged 
PDZRN3A was ﬂ  anked by promoter and enhancer se-
quences from the myosin light chain (MLC) 1f/3f gene to 
drive muscle speciﬁ  c expression. (B) RT-PCR shows that 
the HA-PDZRN3A transgene is expressed in skeletal 
muscle, but not in the spinal cord, brain, heart, kidney, 
lung, or liver of a P21 transgenic mouse. mRNA of the 
ribosomal protein rig/S15 was ampliﬁ  ed as a control 
(bottom panel). (C) mRNA from the HA-PDZRN3A trans-
gene is detected by RT-PCR in the skeletal muscle from 
E15.5 but not E14.5 embryos. (D) Western blot reveals 
the presence of HA-PDZRN3A protein in skeletal muscle 
from a transgenic E15.5 embryo. Blot was reprobed for 
β-tubulin as a loading control. (E) Western blot of mus-
cles from P21 transgenic mice (TG) and wild-type litter-
mates (WT) probed with an anti-HA antibody and an 
anti-PDZRN3 antibody. (F) Cross sections of muscles 
from P21 transgenic and wild-type littermates stained 
with α-BTX and an anti-HA antibody. HA-PDZRN3A is 
localized at the NMJ of transgenic mice. Bar, 10 μm. 
(G) Cross-sections of muscles from P21 transgenic and 
wild-type littermates stained with α-BTX and an anti-
MuSK antibody. Four representative NMJs are shown for 
each genotype. MuSK expression at the NMJ is much 
lower in transgenic mice than that in wildtype litter  mates. 
Bar, 10 μm. (H) Quantiﬁ  cation of ﬂ  uorescence intensity 
of MuSK staining at the NMJ in transgenic mice and 
wild-type littermates (mean ± SEM, n = 20), ***, P < 
0.001. (I and J) Wholemount staining of gluteus muscles 
with α-BTX and antibodies against neuroﬁ  lament  (NF) 
and synaptophysin (SYP). NMJs from P0, P8, and P21 
transgenic mice (J) are smaller than those from wild-type 
littermates (I). NMJs in P8 and P21 transgenic mice are 
much less complex than those from wild-type littermates. 
Bars, 10 μm. (K) Quantiﬁ  cation of areas of NMJs from 
transgenic and wildtype littermates (mean ± SEM; n is 
shown inside the bar [from 2–3 mice]). ***, P < 0.001. 
(L) The complexity of NMJs is quantiﬁ  ed by the number 
of perforations in each NMJ. NMJs from P21 transgenic 
mice have fewer perforations than those from wild-type 
littermates (n is 111 for wild-type and 103 for trans-
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mice was only 40% of that in wild-type littermates (Fig. 7, 
G and H), indicating that overexpression of PDZRN3A leads to 
reduced MuSK expression at the NMJ.
We next examined the development of the NMJ using 
wholemount staining of gluteus muscle with anti-synaptophysin/
anti-neurofi  lament antibodies and α-BTX. In wild-type mice, 
NMJs grow from “plaque-like” at P0 to “donut-like” by the end 
of the fi  rst postnatal week (Fig. 7 I). At 3 wk of age, NMJs in 
wild-type mice are well developed with complex patterns of 
multi-bifurcated presynaptic nerve terminals and “pretzel-like” 
perforated postsynaptic AChR clusters (Fig. 7 I). In the MLC-
PDZRN3A transgenic mice, however, NMJs were much smaller 
in size at all three stages (P0, P8, and P21) examined (Fig. 7, 
J and K). Morphologically, NMJs in the transgenic mice re-
mained plaque-like at P8. This is even more profound at P21; 
both presynaptic nerve terminals and postsynaptic AChR clus-
ters showed much less complexity (Fig. 7 J) compared with the 
wild-type littermates (Fig. 7 I). Postsynaptic AChR clusters of 
many NMJs were still plaque-like with few perforations, a hall-
mark of immature NMJs. To measure the complexity of the 
NMJ quantitatively, we counted the perforations of each NMJ 
and used this number as a “complexity index”. As shown in Fig. 
7 L, NMJs in MLC-PDZRN3A transgenic mice contained many 
fewer perforations. These data strongly suggest that overexpres-
sion of PDZRN3A in muscle severely perturbs the growth and 
maturation of the NMJ.
Discussion
Although the importance of ubiquitin-dependent pathways in 
vertebrate synaptic development and plasticity has been well 
recognized, the specifi  c E3 ubiquitin ligases involved in the ubiq-
uitination of synaptic proteins are largely unknown (Colledge 
et al., 2003; DiAntonio and Hicke, 2004). In this study, we iden-
tifi  ed PDZRN3, a synapse-associated RING-type E3 ubiquitin 
ligase, as an important regulator of synaptic growth and matura-
tion at the NMJ. We show that PDZRN3 is highly expressed in 
muscle and specifi  cally localized to the postsynaptic site of the 
NMJ. PDZRN3 directly interacts with MuSK, and this inter-
action is enhanced by agrin stimulation. Coexpression of PDZRN3 
and MuSK in heterologous cells promotes the ubiquitination 
of MuSK, and leads to enhanced endocytosis and reduced sur-
face expression of MuSK. These effects require the RING 
domain of PDZRN3, which contains the E3 ubiquitin ligase 
activity. Overexpression of PDZRN3 leads to attenuated MuSK-
dependent AChR clustering in cultured myotubes. Knockdown 
of endogenous PDZRN3 by RNAi in myotubes results in in-
creased surface levels of MuSK and enhanced AChR clustering 
in response to agrin stimulation. Furthermore, overexpresion of 
PDZRN3 in muscle of transgenic mice perturbs the growth and 
maturation of the NMJ. Together, these data provide strong 
evidence that PDZRN3 functions as a synapse-associated E3 
ubiquitin ligase to regulate the postsynaptic devel  opment of 
the NMJ.
MuSK is essential for all aspects of postsynaptic differen-
tiation of the NMJ (Sanes and Lichtman, 2001; Burden, 2002; 
Willmann and Fuhrer, 2002). Therefore, modulation of MuSK 
level/activity might serve as a central point of regulation in the 
formation and maintenance of the NMJ. In cultured myotubes, 
agrin-induced MuSK phosphorylation is transient, suggesting 
the existence of mechanisms rapidly regulating MuSK level 
and/or phosphorylation (Fuhrer et al., 1997; Mittaud et al., 
2004). Transgenic expression of a constitutively active MuSK 
in mice leads to the formation of extrasynaptic clusters of 
AChRs (Jones et al., 1999). Furthermore, patients with a mis-
sense mutation of MuSK that leads to low levels of MuSK expres-
sion have reduced AChR clusters and show signs of myasthenic 
syndrome (Chevessier et al., 2004). This demonstrates the 
  importance of precise control of MuSK level/activity in the de-
velopment and function of the NMJ. Although several MuSK-
interacting proteins have been identifi  ed that may serve as points 
of regulation (Strochlic et al., 2001, 2004; Luo et al., 2002, 
2003; Finn et al., 2003; Bromann et al., 2004; Madhavan et al., 
2005; Okada et al., 2006), our study presents a molecular mech-
anism of direct regulation of MuSK activity through the modu-
lation of its surface levels.
The enrichment of PDZRN3 mRNA in the synaptic re-
gion of the muscle and the concentration of PDZRN3 protein at 
the NMJ are consistent with our fi  ndings of its role in regulating 
MuSK signaling. However, a recent study also showed that 
PDZRN3 is expressed in cultured myoblasts and that its expres-
sion is up-regulated during the differentiation of C2C12 myo-
blasts into myotubes (Ko et al., 2006). Knockdown of PDZRN3 
in cultured C2C12 cells inhibits the formation of myotubes, 
though overexpression of PDZRN3 has no effect on the differ-
entiation of myoblasts into myotubes (Ko et al., 2006). This is 
in contrast with results of our RNAi experiments, which show 
no effects on the formation of myotubes. In our study, C2C12 
cells expressing the RNAi construct for PDZRN3 grow and fuse 
in a fashion indistinguishable from wild-type C2C12 myotubes. 
Furthermore, these myotubes have a similar response to high 
concentrations of agrin stimulation as control myotubes. Cur-
rently, the reason for this discrepancy is not clear. One obvious 
difference is the method of expressing RNAi constructs in 
C2C12 cells. Ko et al. (2006) used a transient expression ap-
proach by transfecting the same batch of C2C12 cells for three 
consecutive times at 24-h intervals to reach high transfection 
effi  ciency. We selected stably transfected C2C12 cells to enrich 
cells expressing the RNAi construct. In general, the expression 
level of exogenous gene is lower in stably transfected cells than 
in transiently transfected cells due to lower copy numbers. We 
saw  75% reduction of endogenous PDZRN3 proteins in myo-
tubes expressing the RNAi construct for PDZRN3. Future gene 
knockout studies in mice will likely resolve this difference.
In mice, NMJs start to form around E14.5 (Lin et al., 2001). 
We have shown that PDZRN3 protein is fi  rst detected at the NMJ 
around E16.5, suggesting that the role of PDZRN3 at the NMJ 
is unlikely to be in the initial formation of the NMJ, but rather in 
the growth and/or maturation of the NMJ. This role is further 
supported by our study of transgenic mice. Overexpression of 
PDZRN3 in skeletal muscle leads to reduced MuSK expression at 
the NMJ and smaller and less mature NMJs. Because PDZRN3 
contains multiple protein–protein interaction domains, we cannot 
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affect additional signaling pathways in muscles. However, our 
results are consistent with the proposed role of synaptic E3 ubiqui-
tin ligases in regulating homeostatic growth of synapses in Droso-
phila and C. elegans, in which mutations of E3 ubiquitin ligases 
lead to aberrant growth of synapses (Schaefer et al., 2000; Wan 
et al., 2000; Zhen et al., 2000; DiAntonio et al., 2001).
Although ubiquitination-mediated protein degradation 
through the 26S proteasome is the best characterized function 
of the ubiquitin system, increasing evidence suggests that ubiq-
uitination-mediated endocytosis and lysosomal degradation 
play an important role in regulating cell surface abundance of 
membrane proteins (Hicke, 2001). Initial studies from yeast in-
dicate that monoubiquitination of membrane proteins is suffi  -
cient for triggering endocytosis (Hicke, 2001). However, recent 
studies suggest that polyubiquitination, rather than monoubiq-
uitination, is required as a signal for endocytosis in mammalian 
cells (Barriere et al., 2006; Hawryluk et al., 2006). Our data 
strongly suggest that PDZRN3 functions as an E3 ubiquitin li-
gase to regulate surface levels of MuSK through ubiquitination-
dependent endocytosis. Ubiquitination-mediated endocytosis 
has been shown to be a key mechanism of down-regulating re-
ceptor tyrosine kinase activity in many cellular processes (Marmor 
and Yarden, 2004). Recently, a putative Ariadne-like ubiquitin 
ligase (PAUL) has been found to be present at the NMJ and to 
interact with MuSK (Bromann et al., 2004). Together, these 
synaptically localized E3 ubiquitin ligases may play an impor-
tant role in postsynaptic development at the NMJ through the 
regulation of surface levels of MuSK.
Materials and methods
Antibodies and constructs
Rabbit anti-PDZRN3 antibody (PDZRN3-10B) and guinea pig anti-PDZRN3 
antibody (PDZRN3-3B) were raised against hexahistidine tagged amino 
acids 83–134 and 468–628 of PDZRN3A, respectively. Anti-MuSK C-19 
(Santa Cruz Biotechnology, Inc.), anti-MuSK N-19 (Santa Cruz Biotechnol-
ogy, Inc.), anti-MuSK (Abcam), anti-MuSK #83033 (a gift from Dr. Steve 
Burden, New York University, New York, NY), anti-ubiquitin (Sigma-
Aldrich), anti-β-tubulin (Sigma-Aldrich), anti-FLAG M2 (Sigma-Aldrich), 
anti-β-actin (Sigma-Aldrich), anti-transferrin receptor (Zymed Laboratories), 
anti-GAPDH (Zymed Laboratories), and anti-synaptophysin antibodies 
(Synaptic Systems GmbH) were used for immunoprecipitation and Western 
blot. AlexaFluor 488–, rhodamine-, and AlexaFluor 647–conjugated 
α-bungarotoxin (Invitrogen) were used for staining of AChRs.
PDZRN3A∆RING, PDZRN3A∆RZ, and PDZRN3A∆PDZ were gener-
ated by deleting amino acids 1–51, 1–157, and 246–338 of PDZRN3A, 
respectively. Kinase-dead MuSK was generated by replacing Lys608 with 
Ala, and kinase-active MuSK was generated by deleting amino acids 99–492 
from the ectodomain of MuSK (Zhou et al., 1999).
Coimmunoprecipitation
C2C12 myotubes or transfected COS-7 cells were harvested and lysed in 
lysis buffer containing PBS, 1% Triton X-100, and Complete protease inhib-
itors (Roche). Immunoprecipitation was performed by incubating samples 
with appropriate antibodies and 25 μl of protein A agarose beads (Invitro-
gen) for 2–4 h. Proteins were eluted by the addition of loading buffer and 
analyzed by Western blot.
Immunohistochemistry
Tibialis anterior muscle was denervated, sectioned, and stained as de-
scribed previously (Young et al., 2005). Fluorescent images were taken us-
ing an Axioskop2 Plus microscope (Carl Zeiss MicroImaging, Inc.) ﬁ  tted 
with an AxioCam CCD camera (Carl Zeiss MicroImaging, Inc.) through 
a 20× objective (NA = 0.75) with acquisition software AxioVision 3.1 
(Carl Zeiss MicroImaging, Inc.). Images were then adjusted with Adobe 
Photoshop 6.0 (cropping and brightness/contrast adjustments). Final 
  ﬁ  gures were mounted and labeled using Adobe Illustrator 9.0.
C2C12 myoblast transfection
C2C12 myoblasts were plated in 6-well plates and transfected with a total 
of 2 μg DNA and 3 μl FuGENE 6 (Roche) per well. 36–48 h after transfec-
tion, myoblasts were switched to fusion medium (DME with 2% horse 
serum) to allow myoblasts to fuse into myotubes for 4–5 d. After stimulation 
with 1 nM agrin (R&D Systems) for 12–16 h, myotubes were ﬁ  xed and 
stained with appropriate antibodies.
Biotinylation and endocytosis assay
C2C12 myotubes or transfected COS-7 cells were washed with PBS and 
surface biotinylated as described previously (Ehlers, 2000). For the endo-
cytosis assay, two sets of identically transfected COS-7 cells were prepared 
and surface biotinylated. One set of samples was moved to 37°C for 10 min 
to allow endocytosis to occur. The remaining surface biotin was then 
cleaved with glutathione cleavage buffer (50 mM glutathione, 75 mM 
NaCl, 10 mM EDTA, 1% BSA, and 0.075 N NaOH). The other set was 
kept on ice without subsequent cleavage and used to determine the initial 
surface levels of MuSK. The relative endocytosis of MuSK from the cell sur-
face was then calculated by determining the ratio of biotinylated MuSK 
after cleavage to the initial surface-biotinylated MuSK.
Ubiquitination assays
The in vitro ubiquitination assay was performed by incubating GST-FLAG-
RING (GST and FLAG tagged RING domain of PDZRN3A) with 5 nM 
yeast E1, 100 nM of the indicated E2, and ubiquitin (Boston Biochem) in 
ubiquitination buffer (50 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 1 mM DTT, 
1 mM ATP, 10 mM creatine phosphate, and 16 IU/ml creatine phospho-
kinase) to a ﬁ  nal volume of 40 μl. Samples were incubated at 30°C for 2 h 
and subsequently analyzed by Western blot. To detect ubiquitination of 
MuSK, transfected COS-7 cells or C2C12 myotubes stimulated with 10 nM 
agrin for 2 h were harvested in lysis buffer containing 2% SDS. After incu-
bating at 4°C for 1 h, samples were diluted 1:20 using lysis buffer without 
SDS, and MuSK was immunoprecipitated and analyzed by Western blot 
with an anti-ubiquitin antibody (Sigma-Aldrich).
GST pull-down assay
GST or GST-UbcH5B proteins were immobilized on glutathione-sepharose 
beads (Novagen). Whole cell lysate from PDZRN3A transfected COS-7 
cells was added and incubated with these beads at 4°C for 1–2 h. Proteins 
were then eluted and analyzed by Western blot.
RNA interference
The full-length mouse PDZRN3A sequence was copied into the siRNA 
design center of DHARMACON (http://www.dharmacon.com/sidesign/
default.aspx?source=0) and four oligo sequences against PDZRN3A were 
generated. These oligo sequences were inserted into pSuper vector and 
cotransfected with PDZRN3A into COS-7 cells. Western blot analysis 
showed that one oligo (sequence 5′-G  T  C  G  G  T  G  A  C  T  A  C  T  G  T  A  T  A  A  -3′) had 
the most dramatic effect in knocking down expression of PDZRN3A. 
C2C12 stable cell lines expressing either this oligo or another oligo with a 
scrambled sequence were then generated by transfection of C2C12 cells 
with subsequent G418 selection.
Transgenic mice
The MLC-PDZRN3A transgene was constructed by inserting HA-tagged 
mouse PDZRN3A cDNA in the vector containing the promoter and en-
hancer elements from the rat MLC 1f/3f gene (Feng et al., 2000). Trans-
genic mice were generated by injection of DNA into the fertilized oocyte 
using standard pronuclear injection techniques. Transgenic founders were 
subsequently backcrossed to C57BL6/J mice for two to four generations 
before analysis. Genotypes were determined by PCR, and wild-type littermates 
of transgenic mice were used as controls.
Online supplemental material
Fig. S1 A shows weak staining of extrasynaptic muscle membrane by anti-
PDZRN3 antibody; B and C shows that MuSK staining persists after de-
nervation. Fig. S2 shows how regulation of surface levels of MuSK by 
PDZRN3 is speciﬁ  c. Fig. S3 describes how down-regulation of surface lev-
els of MuSK by PDZRN3 is blocked by the lysosome inhibitor chloroquine, 
but not the proteasome inhibitor MG-132. Fig. S4 shows C2C12 cells sta-
bly transfected with PDZRN3 siRNA fuse in a fashion indistinguishable 
from controls. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200610060/DC1.JCB • VOLUME 177 • NUMBER 6 • 2007  1088
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